Healthcare Sector Stocks
The Healthcare sector has a total of 1054 stocks, with a combined market cap of $9.58 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.86.
Market Cap
9.58T
Revenue
4.67T
Profits
188.33B
PE Ratio
50.86
Profit Margin
4.03%
Dividend Yield
0.38%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.13T | -2.98% | 1,476,640 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 636.04B | -1.38% | 3,116,208 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 506.03B | 0.41% | 2,738,335 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 374.62B | -1.79% | 2,557,829 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 358.13B | -1.41% | 6,028,910 | 66.57B |
| 6 | NVS | Novartis AG | 283.68B | -3.81% | 3,726,465 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 263.65B | -0.90% | 2,345,674 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 247.99B | -0.86% | 1,202,603 | 47.35B |
| 9 | AMGN | Amgen Inc. | 237.69B | -1.70% | 1,043,072 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 194.38B | -0.27% | 3,220,720 | 30.46B |
| 11 | ABT | Abbott Laboratories | 179.73B | 1.33% | 5,395,211 | 48.23B |
| 12 | PFE | Pfizer Inc. | 171.28B | -1.22% | 17,736,469 | 63.70B |
| 13 | NVO | Novo Nordisk A/S | 169.55B | -1.24% | 6,160,861 | 50.34B |
| 14 | DHR | Danaher Corporation | 160.79B | -0.52% | 2,078,711 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 156.95B | 2.01% | 2,323,968 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 133.04B | -1.92% | 489,099 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 125.89B | -2.17% | 4,961,268 | 49.19B |
| 18 | CVS | CVS Health Corporation | 119.38B | -1.21% | 2,106,190 | 412.65B |
| 19 | SYK | Stryker Corporation | 118.25B | 0.39% | 1,080,180 | 25.84B |
| 20 | MDT | Medtronic plc | 117.27B | -0.82% | 3,904,513 | 37.54B |
| 21 | MCK | McKesson Corporation | 116.32B | -1.45% | 371,520 | 410.98B |
| 22 | HCA | HCA Healthcare, Inc. | 101.69B | 0.51% | 701,182 | 78.01B |
| 23 | GSK | GSK plc | 100.54B | -0.96% | 2,497,590 | 44.05B |
| 24 | SNY | Sanofi | 98.37B | -1.07% | 1,708,983 | 55.89B |
| 25 | ELV | Elevance Health, Inc. | 94.94B | -1.31% | 841,159 | 201.83B |
| 26 | CI | The Cigna Group | 80.90B | -3.08% | 1,058,698 | 282.38B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 80.51B | -1.56% | 350,705 | 15.53B |
| 28 | MRNA | Moderna, Inc. | 78.88B | -2.50% | 18,947,761 | 2.23B |
| 29 | BSX | Boston Scientific Corporation | 66.26B | -0.63% | 5,837,276 | 21.00B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 64.51B | -0.59% | 1,819,663 | 28.42B |
| 31 | COR | Cencora, Inc. | 63.26B | -2.05% | 495,634 | 332.77B |
| 32 | NTRA | Natera, Inc. | 58.09B | 0.41% | 786,903 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 57.95B | -2.10% | 616,216 | 254.25B |
| 34 | ARGX | argenx SE | 54.81B | 0.06% | 231,645 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 54.33B | -0.48% | 690,466 | 22.48B |
| 36 | VEEV | Veeva Systems Inc. | 52.35B | 0.24% | 852,963 | 3.46B |
| 37 | EW | Edwards Lifesciences Corporation | 51.49B | -0.84% | 1,482,657 | 6.51B |
| 38 | HUM | Humana Inc. | 50.43B | -0.23% | 630,312 | 145.68B |
| 39 | A | Agilent Technologies, Inc. | 48.58B | -0.91% | 1,044,188 | 7.37B |
| 40 | IQV | IQVIA Holdings Inc. | 45.93B | 0.27% | 539,827 | 16.98B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 45.88B | -2.09% | 4,216,884 | 17.32B |
| 42 | MDLN | Medline Inc. | 44.85B | -2.19% | 4,833,431 | 29.94B |
| 43 | HLN | Haleon plc | 44.46B | -1.01% | 10,205,641 | 14.80B |
| 44 | WAT | Waters Corporation | 44.40B | -0.80% | 645,659 | 4.64B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 44.33B | -0.73% | 219,343 | 4.55B |
| 46 | ONC | BeOne Medicines AG | 42.98B | -1.12% | 256,120 | 6.13B |
| 47 | ILMN | Illumina, Inc. | 40.69B | 0.03% | 799,751 | 4.49B |
| 48 | RVMD | Revolution Medicines, Inc. | 40.31B | 0.20% | 888,293 | - |
| 49 | BIIB | Biogen Inc. | 37.16B | -0.93% | 658,547 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 36.61B | -0.13% | 1,804,626 | 2.54B |
| 51 | RMD | ResMed Inc. | 35.71B | 0.33% | 542,577 | 5.65B |
| 52 | CNC | Centene Corporation | 34.69B | -1.43% | 2,738,590 | 180.30B |
| 53 | ALC | Alcon Inc. | 33.85B | -0.32% | 2,024,989 | 10.86B |
| 54 | ZTS | Zoetis Inc. | 33.43B | -1.34% | 1,479,811 | 9.53B |
| 55 | MTD | Mettler-Toledo International Inc. | 33.23B | -1.55% | 117,731 | 4.13B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 32.42B | 0.56% | 1,802,984 | 21.27B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.00B | -1.37% | 665,100 | 4.80B |
| 58 | DXCM | DexCom, Inc. | 29.59B | 0.11% | 3,153,600 | 4.97B |
| 59 | WST | West Pharmaceutical Services, Inc. | 27.53B | -0.72% | 381,220 | 3.33B |
| 60 | LH | Labcorp Holdings Inc. | 26.85B | 0.34% | 350,333 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.80B | -0.20% | 518,406 | 11.84B |
| 62 | ROIV | Roivant Sciences Ltd. | 26.39B | -2.46% | 6,093,553 | 7.53M |
| 63 | PHG | Koninklijke Philips N.V. | 26.17B | -0.02% | 847,810 | 20.18B |
| 64 | GMAB | Genmab A/S | 26.15B | 10.02% | 10,062,732 | 4.13B |
| 65 | UTHR | United Therapeutics Corporation | 25.10B | 0.08% | 265,731 | 3.15B |
| 66 | INCY | Incyte Corporation | 23.54B | -0.70% | 723,872 | 5.82B |
| 67 | GH | Guardant Health, Inc. | 22.98B | 5.09% | 1,144,573 | 1.18B |
| 68 | STE | STERIS plc | 22.68B | 0.16% | 329,115 | 6.04B |
| 69 | BNTX | BioNTech SE | 22.13B | -1.74% | 508,526 | 3.03B |
| 70 | THC | Tenet Healthcare Corporation | 21.61B | -0.84% | 213,618 | 21.81B |
| 71 | VTRS | Viatris Inc. | 20.76B | -2.22% | 3,923,410 | 14.74B |
| 72 | INSM | Insmed Incorporated | 20.47B | -1.41% | 1,918,822 | 1.14B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.80B | -0.25% | 1,117,005 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.64B | 1.90% | 223,795 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.66B | 0.61% | 634,520 | 2.91B |
| 76 | CRL | Charles River Laboratories International, Inc. | 16.47B | 1.56% | 547,909 | 4.00B |
| 77 | EXEL | Exelixis, Inc. | 16.03B | -0.92% | 1,019,299 | 2.44B |
| 78 | ASND | Ascendis Pharma A/S | 15.97B | 0.08% | 414,347 | 1.20B |
| 79 | SOLV | Solventum Corporation | 14.58B | -2.06% | 1,175,924 | 8.31B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.45B | -0.80% | 645,923 | 3.37B |
| 81 | HALO | Halozyme Therapeutics, Inc. | 14.28B | 1.06% | 1,069,429 | 1.66B |
| 82 | ICLR | ICON Public Limited Company | 14.20B | -0.74% | 648,888 | 8.29B |
| 83 | JAZZ | Jazz Pharmaceuticals plc | 13.87B | -0.47% | 277,191 | 4.60B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.36B | 0.32% | 1,659,972 | 713.07M |
| 85 | BAX | Baxter International Inc. | 13.15B | -0.86% | 2,940,651 | 11.47B |
| 86 | PEN | Penumbra, Inc. | 12.80B | 0.02% | 274,216 | 1.50B |
| 87 | SNN | Smith & Nephew plc | 12.68B | -0.05% | 1,021,487 | 6.30B |
| 88 | BTSG | BrightSpring Health Services, Inc. | 12.46B | -1.69% | 1,050,685 | 14.37B |
| 89 | SMMT | Summit Therapeutics Inc. | 12.39B | -0.39% | 2,352,934 | - |
| 90 | TEM | Tempus AI, Inc. | 12.27B | 6.57% | 3,213,442 | 1.43B |
| 91 | EHC | Encompass Health Corporation | 12.24B | -1.54% | 370,759 | 6.21B |
| 92 | FMS | Fresenius Medical Care AG | 11.85B | 1.89% | 549,219 | 22.19B |
| 93 | DVA | DaVita Inc. | 11.80B | -0.59% | 404,036 | 14.01B |
| 94 | COO | The Cooper Companies, Inc. | 11.66B | -0.57% | 991,894 | 4.24B |
| 95 | AVTR | Avantor, Inc. | 11.62B | 0.17% | 5,100,124 | 6.56B |
| 96 | TECH | Bio-Techne Corporation | 11.39B | -0.01% | 1,137,169 | 1.22B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.35B | 0.09% | 2,402,472 | 5.02B |
| 98 | UHS | Universal Health Services, Inc. | 11.06B | -0.21% | 199,664 | 18.11B |
| 99 | ALGN | Align Technology, Inc. | 10.98B | -0.57% | 513,798 | 4.14B |
| 100 | GMED | Globus Medical, Inc. | 10.95B | -0.09% | 425,252 | 3.14B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.82B | -1.25% | 1,006,702 | 3.41B |
| 102 | MOH | Molina Healthcare, Inc. | 10.80B | -4.26% | 807,910 | 42.08B |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.74B | - | 3,007,313 | 3.44B |
| 104 | GKOS | Glaukos Corporation | 10.53B | 1.08% | 506,706 | 612.84M |
| 105 | QGEN | Qiagen N.V. | 10.42B | 0.31% | 5,653,912 | 2.10B |
| 106 | PODD | Insulet Corporation | 10.38B | 1.00% | 471,612 | 3.05B |
| 107 | ENSG | The Ensign Group, Inc. | 10.19B | -1.17% | 127,894 | 5.49B |
| 108 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.11B | -3.43% | 137,187 | 1.28B |
| 109 | RGEN | Repligen Corporation | 9.92B | -1.60% | 614,069 | 785.10M |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 9.81B | 0.98% | 87,002 | 2.59B |
| 111 | PCVX | Vaxcyte, Inc. | 9.55B | -3.48% | 1,294,581 | - |
| 112 | OSCR | Oscar Health, Inc. | 9.53B | -7.23% | 2,292,995 | 15.32B |
| 113 | HSIC | Henry Schein, Inc. | 9.48B | -1.10% | 415,372 | 13.60B |
| 114 | TXG | 10x Genomics, Inc. | 9.27B | 1.99% | 1,351,855 | 616.91M |
| 115 | CORT | Corcept Therapeutics Incorporated | 9.26B | -20.32% | 2,204,590 | 830.81M |
| 116 | KRYS | Krystal Biotech, Inc. | 9.23B | -2.61% | 137,087 | 440.48M |
| 117 | KYMR | Kymera Therapeutics, Inc. | 9.21B | -0.04% | 214,437 | 105.00M |
| 118 | CAI | Caris Life Sciences, Inc. | 8.99B | 0.32% | 1,584,941 | 989.61M |
| 119 | HNGE | Hinge Health, Inc. | 8.98B | 1.20% | 723,379 | 720.06M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 8.92B | -1.23% | 218,229 | 281.99M |
| 121 | IBRX | ImmunityBio, Inc. | 8.74B | -0.78% | 4,251,527 | 165.79M |
| 122 | BRKR | Bruker Corporation | 8.73B | -0.02% | 868,688 | 3.50B |
| 123 | TWST | Twist Bioscience Corporation | 8.65B | 1.82% | 1,179,812 | 431.80M |
| 124 | HQY | HealthEquity, Inc. | 8.58B | 2.75% | 592,891 | 1.36B |
| 125 | CYTK | Cytokinetics, Incorporated | 8.54B | -1.44% | 521,196 | 67.67M |
| 126 | SYRE | Spyre Therapeutics, Inc. | 8.46B | -1.91% | 281,127 | - |
| 127 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.19B | -0.64% | 492,708 | 669.50M |
| 128 | ATR | AptarGroup, Inc. | 8.07B | -0.96% | 202,914 | 3.93B |
| 129 | ABVX | ABIVAX Société Anonyme | 7.76B | -2.70% | 333,212 | 5.33M |
| 130 | TGTX | TG Therapeutics, Inc. | 7.75B | 2.79% | 1,330,272 | 799.54M |
| 131 | AXSM | Axsome Therapeutics, Inc. | 7.60B | -7.00% | 1,270,560 | 776.57M |
| 132 | PACS | PACS Group, Inc. | 7.58B | 0.76% | 911,080 | 5.55B |
| 133 | ALKS | Alkermes plc | 7.32B | -1.22% | 451,307 | 1.67B |
| 134 | IONS | Ionis Pharmaceuticals, Inc. | 7.11B | -2.57% | 1,851,384 | 874.09M |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 7.09B | -0.63% | 855,956 | 3.12B |
| 136 | PRAX | Praxis Precision Medicines, Inc. | 7.05B | -2.53% | 220,010 | 7.46M |
| 137 | GRFS | Grifols, S.A. | 6.79B | 1.07% | 860,557 | 8.48B |
| 138 | CHE | Chemed Corporation | 6.66B | -1.57% | 80,594 | 2.60B |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.52B | -0.22% | 377,321 | 1.56B |
| 140 | HIMS | Hims & Hers Health, Inc. | 6.51B | -4.15% | 6,873,774 | 2.58B |
| 141 | IOVA | Iovance Biotherapeutics, Inc. | 6.35B | -0.92% | 5,875,687 | 324.97M |
| 142 | BLCO | Bausch + Lomb Corporation | 6.22B | -0.11% | 282,421 | 5.32B |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.15B | -1.73% | 252,176 | 239.92M |
| 144 | LGND | Ligand Pharmaceuticals Incorporated | 6.09B | -0.70% | 201,695 | 290.54M |
| 145 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.05B | -4.05% | 313,626 | 840.85M |
| 146 | BLTE | Belite Bio, Inc | 5.94B | -1.81% | 34,314 | - |
| 147 | DOCS | Doximity, Inc. | 5.93B | -1.19% | 879,859 | 655.57M |
| 148 | GRAL | GRAIL, Inc. | 5.89B | 3.85% | 394,521 | 165.26M |
| 149 | IMVT | Immunovant, Inc. | 5.89B | -1.96% | 302,102 | - |
| 150 | MANE | Veradermics, Incorporated | 5.83B | 0.73% | 290,973 | - |
| 151 | TFX | Teleflex Incorporated | 5.79B | 0.01% | 259,601 | 2.25B |
| 152 | MMSI | Merit Medical Systems, Inc. | 5.58B | -0.55% | 411,476 | 1.58B |
| 153 | WAY | Waystar Holding Corp. | 5.56B | 0.09% | 847,596 | 1.21B |
| 154 | RDNT | RadNet, Inc. | 5.52B | -0.09% | 232,205 | 2.27B |
| 155 | CGON | CG Oncology, Inc. | 5.46B | -1.42% | 308,025 | 6.23M |
| 156 | KOD | Kodiak Sciences Inc. | 5.43B | 0.97% | 317,281 | - |
| 157 | HAE | Haemonetics Corporation | 5.40B | 2.13% | 423,498 | 1.35B |
| 158 | COGT | Cogent Biosciences, Inc. | 5.39B | -0.83% | 969,963 | - |
| 159 | ORKA | Oruka Therapeutics, Inc. | 5.32B | -0.97% | 252,003 | - |
| 160 | STVN | Stevanato Group S.p.A. | 5.30B | -0.56% | 261,420 | 1.40B |
| 161 | MIRM | Mirum Pharmaceuticals, Inc. | 5.26B | -2.53% | 409,658 | 618.07M |
| 162 | MMED | MiniMed Group, Inc. | 5.16B | 0.33% | 2,974,973 | 3.22B |
| 163 | SHC | Sotera Health Company | 5.13B | -0.91% | 980,752 | 1.22B |
| 164 | BLLN | BillionToOne, Inc. | 5.08B | 1.97% | 352,245 | 397.41M |
| 165 | SRRK | Scholar Rock Holding Corporation | 5.04B | -1.33% | 743,325 | - |
| 166 | CON | Concentra Group Holdings Parent, Inc. | 5.03B | -1.23% | 761,862 | 2.29B |
| 167 | PTCT | PTC Therapeutics, Inc. | 5.03B | -4.35% | 361,977 | 1.01B |
| 168 | ERAS | Erasca, Inc. | 5.01B | 1.99% | 1,975,607 | - |
| 169 | HTFL | HeartFlow, Inc. | 4.92B | 2.12% | 1,154,076 | 212.07M |
| 170 | LFST | LifeStance Health Group, Inc. | 4.92B | 2.47% | 1,641,642 | 1.58B |
| 171 | DFTX | Definium Therapeutics, Inc. | 4.83B | -0.25% | 1,231,927 | - |
| 172 | CRSP | CRISPR Therapeutics AG | 4.76B | -1.44% | 1,572,981 | 13.39M |
| 173 | TVTX | Travere Therapeutics, Inc. | 4.71B | -4.62% | 824,454 | 591.33M |
| 174 | OPCH | Option Care Health, Inc. | 4.68B | -0.11% | 1,629,788 | 5.69B |
| 175 | LIVN | LivaNova PLC | 4.46B | -0.30% | 307,291 | 1.47B |
| 176 | ITGR | Integer Holdings Corporation | 4.30B | 0.03% | 367,038 | 1.84B |
| 177 | DNTH | Dianthus Therapeutics, Inc. | 4.28B | -2.60% | 218,697 | 1.90M |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 4.25B | -2.13% | 236,199 | - |
| 179 | ICUI | ICU Medical, Inc. | 4.14B | -1.56% | 165,588 | 2.16B |
| 180 | INDV | Indivior Pharmaceuticals, Inc. | 4.07B | -2.45% | 1,039,426 | 1.33B |
| 181 | ADPT | Adaptive Biotechnologies Corporation | 4.04B | 3.77% | 1,040,348 | 308.08M |
| 182 | IRTC | iRhythm Holdings, Inc. | 3.98B | 1.03% | 332,192 | 825.34M |
| 183 | TNGX | Tango Therapeutics, Inc. | 3.94B | -16.29% | 13,541,271 | 53.81M |
| 184 | RLAY | Relay Therapeutics, Inc. | 3.93B | -2.24% | 1,020,612 | 10.35M |
| 185 | ARQT | Arcutis Biotherapeutics, Inc. | 3.92B | -3.04% | 1,082,804 | 463.98M |
| 186 | PLSE | Pulse Biosciences, Inc. | 3.85B | 2.51% | 345,384 | 1.19M |
| 187 | VCYT | Veracyte, Inc. | 3.83B | 3.54% | 466,255 | 561.90M |
| 188 | ABCL | AbCellera Biologics Inc. | 3.81B | 3.43% | 2,360,422 | 66.17M |
| 189 | NVST | Envista Holdings Corporation | 3.81B | -1.13% | 1,762,088 | 2.86B |
| 190 | LQDA | Liquidia Corporation | 3.79B | 6.68% | 2,741,536 | 450.91M |
| 191 | RGC | Regencell Bioscience Holdings Limited | 3.79B | -22.12% | 429,959 | - |
| 192 | NHC | National HealthCare Corporation | 3.72B | -2.22% | 150,094 | 1.56B |
| 193 | LEGN | Legend Biotech Corporation | 3.71B | 1.22% | 604,719 | 1.27B |
| 194 | OGN | Organon & Co. | 3.61B | 0.04% | 498,954 | 6.13B |
| 195 | CDNA | CareDx, Inc. | 3.58B | 0.01% | 404,212 | 458.09M |
| 196 | XENE | Xenon Pharmaceuticals Inc. | 3.43B | -2.90% | 332,555 | 7.50M |
| 197 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.43B | -4.48% | 744,087 | -665.00K |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.39B | -3.25% | 435,116 | 1.14B |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.35B | -3.75% | 734,832 | 234.13M |
| 200 | IRON | Disc Medicine, Inc. | 3.33B | - | 692,755 | - |
| 201 | CELC | Celcuity Inc. | 3.21B | 0.20% | 949,949 | - |
| 202 | WRBY | Warby Parker Inc. | 3.20B | 0.86% | 1,031,383 | 911.61M |
| 203 | ELVN | Enliven Therapeutics, Inc. | 3.02B | -1.62% | 507,829 | - |
| 204 | TARS | Tarsus Pharmaceuticals, Inc. | 3.01B | -4.80% | 307,989 | 606.33M |
| 205 | ATRC | AtriCure, Inc. | 3.01B | -0.25% | 267,169 | 569.62M |
| 206 | TLX | Telix Pharmaceuticals Limited | 3.01B | -4.35% | 335,719 | 890.79M |
| 207 | PBLS | Parabilis Medicines, Inc. | 2.99B | -10.01% | 1,133,496 | 148.00K |
| 208 | ACHC | Acadia Healthcare Company, Inc. | 2.93B | -1.16% | 730,243 | 3.37B |
| 209 | DNLI | Denali Therapeutics Inc. | 2.93B | -1.69% | 411,433 | 3.60M |
| 210 | AVAH | Aveanna Healthcare Holdings Inc. | 2.92B | 0.38% | 1,057,132 | 2.60B |
| 211 | DYN | Dyne Therapeutics, Inc. | 2.89B | -1.90% | 1,073,891 | - |
| 212 | PRVA | Privia Health Group, Inc. | 2.87B | -1.68% | 255,473 | 2.36B |
| 213 | VKTX | Viking Therapeutics, Inc. | 2.86B | -5.25% | 3,167,005 | - |
| 214 | NRIX | Nurix Therapeutics, Inc. | 2.75B | -1.33% | 1,176,506 | 701.94M |
| 215 | ZLAB | Zai Lab Limited | 2.70B | 9.26% | 3,084,089 | 449.61M |
| 216 | NEOG | Neogen Corporation | 2.67B | 2.17% | 1,098,318 | 884.00M |
| 217 | HCM | HUTCHMED (China) Limited | 2.55B | 1.71% | 18,351 | 549.12M |
| 218 | VRDN | Viridian Therapeutics, Inc. | 2.54B | -1.58% | 616,108 | 71.13M |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.49B | -0.86% | 120,244 | 1.46B |
| 220 | TMDX | TransMedics Group, Inc. | 2.48B | -0.56% | 538,484 | 668.47M |
| 221 | CLOV | Clover Health Investments, Corp. | 2.44B | -2.75% | 2,383,920 | 2.48B |
| 222 | BHC | Bausch Health Companies Inc. | 2.41B | -0.62% | 1,457,464 | 10.85B |
| 223 | BKD | Brookdale Senior Living Inc. | 2.41B | -0.98% | 1,889,594 | 2.93B |
| 224 | BEAM | Beam Therapeutics Inc. | 2.39B | -2.48% | 1,044,378 | 156.04M |
| 225 | ADMA | ADMA Biologics, Inc. | 2.39B | -2.69% | 1,082,932 | 512.28M |
| 226 | RCUS | Arcus Biosciences, Inc. | 2.37B | -3.98% | 2,161,046 | 117.00M |
| 227 | SUPN | Supernus Pharmaceuticals, Inc. | 2.36B | -3.45% | 861,560 | 830.44M |
| 228 | NAMS | NewAmsterdam Pharma Company N.V. | 2.35B | -8.90% | 1,736,928 | 7.12M |
| 229 | MBX | MBX Biosciences, Inc. | 2.33B | -3.93% | 364,085 | - |
| 230 | MD | Pediatrix Medical Group, Inc. | 2.32B | -1.22% | 276,756 | 1.95B |
| 231 | SLS | SELLAS Life Sciences Group, Inc. | 2.31B | 0.62% | 2,415,352 | - |
| 232 | CLDX | Celldex Therapeutics, Inc. | 2.29B | 0.62% | 526,469 | 158.00K |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.28B | -2.77% | 345,128 | 1.10B |
| 234 | UFPT | UFP Technologies, Inc. | 2.27B | -1.25% | 76,693 | 631.64M |
| 235 | AUPH | Aurinia Pharmaceuticals Inc. | 2.24B | -2.77% | 404,492 | 311.51M |
| 236 | FTRE | Fortrea Holdings Inc. | 2.24B | -1.63% | 547,377 | 2.68B |
| 237 | PRGO | Perrigo Company plc | 2.24B | -1.59% | 768,744 | 4.14B |
| 238 | AXGN | Axogen, Inc. | 2.23B | 3.79% | 1,647,568 | 251.17M |
| 239 | PGEN | Precigen, Inc. | 2.22B | -3.13% | 2,957,208 | 85.72M |
| 240 | ADUS | Addus HomeCare Corporation | 2.22B | -1.27% | 95,318 | 1.48B |
| 241 | PGNY | Progyny, Inc. | 2.21B | -0.96% | 301,037 | 1.31B |
| 242 | PHVS | Pharvaris N.V. | 2.20B | 2.09% | 487,784 | - |
| 243 | AGIO | Agios Pharmaceuticals, Inc. | 2.19B | -1.24% | 512,463 | 98.34M |
| 244 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | 1.82% | 14,469,448 | 54.86M |
| 245 | VCEL | Vericel Corporation | 2.16B | -1.99% | 281,801 | 306.30M |
| 246 | ALMR | Alamar Biosciences, Inc. | 2.15B | 4.10% | 362,807 | 100.42M |
| 247 | NEO | NeoGenomics, Inc. | 2.12B | 0.92% | 829,471 | 766.30M |
| 248 | BHVN | Biohaven Ltd. | 2.10B | -5.31% | 3,354,827 | - |
| 249 | HRMY | Harmony Biosciences Holdings, Inc. | 2.10B | -0.08% | 1,601,030 | 959.90M |
| 250 | INSP | Inspire Medical Systems, Inc. | 2.06B | -1.79% | 302,354 | 898.74M |
| 251 | SGRY | Surgery Partners, Inc. | 2.05B | -0.63% | 2,429,060 | 3.37B |
| 252 | IMNM | Immunome, Inc. | 2.04B | -1.53% | 742,853 | 4.02M |
| 253 | LKFT | Lakefront Biotherapeutics NV | 2.04B | 0.99% | 178,740 | 1.13B |
| 254 | VERA | Vera Therapeutics, Inc. | 2.02B | -3.27% | 1,300,739 | - |
| 255 | ZYME | Zymeworks Inc. | 2.00B | -1.09% | 799,220 | 37.13M |
| 256 | TRLV | Trulieve Cannabis Corp. | 1.99B | -5.13% | 1,102,066 | 1.14B |
| 257 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.94B | -2.19% | 1,497,396 | 940.61M |
| 258 | ADRX | ADARx Pharmaceuticals, Inc. | 1.93B | -2.43% | 109,527 | 6.13M |
| 259 | LMAT | LeMaitre Vascular, Inc. | 1.93B | -1.15% | 86,503 | 262.43M |
| 260 | ESTA | Establishment Labs Holdings Inc. | 1.92B | 1.28% | 196,228 | 245.82M |
| 261 | ASTH | Astrana Health, Inc. | 1.90B | -2.29% | 79,973 | 3.84B |
| 262 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.89B | 2.83% | 679,636 | 208.78M |
| 263 | XRAY | DENTSPLY SIRONA Inc. | 1.88B | -0.68% | 2,397,257 | 3.64B |
| 264 | SEPN | Septerna, Inc. | 1.87B | -1.92% | 124,924 | 98.88M |
| 265 | XNCR | Xencor, Inc. | 1.86B | -3.25% | 637,486 | 104.97M |
| 266 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -3.52% | 728,838 | 1.97B |
| 267 | XERS | Xeris Biopharma Holdings, Inc. | 1.84B | -7.00% | 1,743,295 | 335.41M |
| 268 | AMN | AMN Healthcare Services, Inc. | 1.83B | 0.99% | 541,202 | 3.43B |
| 269 | MLYS | Mineralys Therapeutics, Inc. | 1.81B | -4.42% | 657,161 | - |
| 270 | PVLA | Palvella Therapeutics, Inc. | 1.80B | -1.43% | 91,364 | - |
| 271 | TRVI | Trevi Therapeutics, Inc. | 1.79B | -2.67% | 916,881 | - |
| 272 | SDGR | Schrödinger, Inc. | 1.79B | 5.75% | 701,607 | 259.04M |
| 273 | BFLY | Butterfly Network, Inc. | 1.78B | -1.98% | 2,592,638 | 112.14M |
| 274 | VIR | Vir Biotechnology, Inc. | 1.78B | 0.67% | 1,243,826 | 303.23M |
| 275 | WGS | GeneDx Holdings Corp. | 1.76B | -11.92% | 1,487,709 | 454.43M |
| 276 | ZBIO | Zenas BioPharma, Inc. | 1.76B | -4.32% | 174,704 | 1.00M |
| 277 | BRVE | Braveheart Bio, Inc. | 1.74B | -1.05% | 79,527 | - |
| 278 | ARDT | Ardent Health, Inc. | 1.73B | -0.81% | 203,090 | 6.41B |
| 279 | ATEC | Alphatec Holdings, Inc. | 1.73B | -1.50% | 2,003,200 | 815.05M |
| 280 | MAZE | Maze Therapeutics, Inc. | 1.72B | -3.04% | 300,862 | 20.00M |
| 281 | OMCL | Omnicell, Inc. | 1.71B | 1.29% | 515,663 | 1.25B |
| 282 | NVCR | NovoCure Limited | 1.71B | -2.58% | 641,920 | 699.19M |
| 283 | HCSG | Healthcare Services Group, Inc. | 1.70B | - | 676,360 | 1.88B |
| 284 | KMTS | Kestra Medical Technologies, Ltd. | 1.70B | 0.71% | 176,246 | 106.73M |
| 285 | PSNL | Personalis, Inc. | 1.69B | 0.03% | 657,425 | 69.67M |
| 286 | URGN | UroGen Pharma Ltd. | 1.68B | -2.39% | 365,093 | 188.73M |
| 287 | KLRA | Kailera Therapeutics, Inc. | 1.65B | -4.22% | 924,186 | - |
| 288 | ALHC | Alignment Healthcare, Inc. | 1.65B | -5.87% | 2,615,231 | 4.58B |
| 289 | ALVO | Alvotech | 1.63B | -4.49% | 526,181 | 494.61M |
| 290 | NUVB | Nuvation Bio Inc. | 1.61B | -2.66% | 1,932,954 | 169.90M |
| 291 | STOK | Stoke Therapeutics, Inc. | 1.61B | -3.15% | 327,342 | 27.59M |
| 292 | NVAX | Novavax, Inc. | 1.61B | -2.55% | 3,104,654 | 413.80M |
| 293 | COAG | Hemab Therapeutics Holdings, Inc. | 1.60B | -1.57% | 170,162 | - |
| 294 | IMCR | Immunocore Holdings plc | 1.60B | -3.30% | 109,504 | 430.78M |
| 295 | SNDA | Sonida Senior Living, Inc. | 1.60B | -0.32% | 205,286 | 481.07M |
| 296 | AZTA | Azenta, Inc. | 1.59B | 0.85% | 276,135 | 613.81M |
| 297 | GENB | Generate Biomedicines, Inc. | 1.59B | -3.28% | 180,010 | 26.48M |
| 298 | MESO | Mesoblast Limited | 1.58B | -2.23% | 77,680 | 120.25M |
| 299 | PAHC | Phibro Animal Health Corporation | 1.58B | -2.03% | 51,747 | 1.52B |
| 300 | TRAX | First Tracks Biotherapeutics, Inc. | 1.58B | 2.50% | 603,971 | - |
| 301 | LYCA | Lycia Therapeutics, Inc. | 1.58B | 68.06% | 2,040,387 | 4.44M |
| 302 | ABSI | Absci Corporation | 1.57B | -2.67% | 1,170,781 | 1.56M |
| 303 | CERT | Certara, Inc. | 1.56B | 1.59% | 910,391 | 421.75M |
| 304 | NTLA | Intellia Therapeutics, Inc. | 1.56B | -0.45% | 2,261,228 | 59.51M |
| 305 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | -1.56% | 155,623 | 978.38M |
| 306 | QURE | uniQure N.V. | 1.55B | -3.50% | 547,444 | 18.67M |
| 307 | CMPS | COMPASS Pathways plc | 1.55B | -4.04% | 842,342 | - |
| 308 | RARE | Ultragenyx Pharmaceutical Inc. | 1.53B | -2.19% | 922,208 | 717.00M |
| 309 | GPCR | Structure Therapeutics Inc. | 1.51B | -3.42% | 548,326 | - |
| 310 | AGL | agilon health, inc. | 1.50B | -1.22% | 131,247 | 5.92B |
| 311 | INVA | Innoviva, Inc. | 1.48B | -2.47% | 488,332 | 440.00M |
| 312 | NBTX | Nanobiotix S.A. | 1.48B | 0.33% | 55,798 | 13.15M |
| 313 | CNMD | CONMED Corporation | 1.47B | -1.06% | 120,333 | 1.37B |
| 314 | AAPG | Ascentage Pharma Group International | 1.46B | 2.61% | 8,899 | 94.61M |
| 315 | PNTG | The Pennant Group, Inc. | 1.46B | -1.02% | 141,301 | 1.10B |
| 316 | NUTX | Nutex Health Inc. | 1.46B | 3.25% | 90,144 | 846.72M |
| 317 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.07% | 345,332 | 746.16M |
| 318 | KRSA | Korsana Biosciences, Inc. | 1.44B | -5.19% | 379,636 | - |
| 319 | ANAB | AnaptysBio, Inc. | 1.44B | -0.08% | 303,648 | 106.09M |
| 320 | ETON | Eton Pharmaceuticals, Inc. | 1.43B | -0.12% | 197,712 | 105.60M |
| 321 | OCUL | Ocular Therapeutix, Inc. | 1.42B | -2.34% | 1,138,011 | 52.06M |
| 322 | TYRA | Tyra Biosciences, Inc. | 1.40B | -2.25% | 313,020 | - |
| 323 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -3.82% | 127,924 | 1.30M |
| 324 | FRNM | Freenome, Inc. | 1.37B | -2.90% | 394,874 | 35.41M |
| 325 | ORIC | ORIC Pharmaceuticals, Inc. | 1.36B | -4.04% | 961,679 | - |
| 326 | USPH | U.S. Physical Therapy, Inc. | 1.31B | -0.72% | 52,250 | 804.27M |
| 327 | INNV | InnovAge Holding Corp. | 1.30B | -0.21% | 266,792 | 989.71M |
| 328 | DMRA | Damora Therapeutics, Inc. | 1.29B | -3.59% | 174,532 | - |
| 329 | NKTR | Nektar Therapeutics | 1.27B | -3.91% | 224,374 | 54.59M |
| 330 | BVS | Bioventus Inc. | 1.26B | -0.47% | 240,033 | 581.85M |
| 331 | TSHA | Taysha Gene Therapies, Inc. | 1.26B | -3.62% | 1,075,734 | 5.49M |
| 332 | LBRX | LB Pharmaceuticals Inc | 1.25B | -1.73% | 105,174 | - |
| 333 | RAPP | Rapport Therapeutics, Inc. | 1.24B | -2.41% | 766,690 | 20.00M |
| 334 | GHRS | GH Research PLC | 1.24B | -2.65% | 441,432 | - |
| 335 | CRON | Cronos Group Inc. | 1.23B | -2.90% | 631,067 | 179.09M |
| 336 | OPK | OPKO Health, Inc. | 1.22B | 0.31% | 1,061,628 | 587.90M |
| 337 | TNDM | Tandem Diabetes Care, Inc. | 1.22B | 2.22% | 1,068,523 | 1.04B |
| 338 | ENOV | Enovis Corporation | 1.22B | -2.27% | 497,030 | 2.30B |
| 339 | DRTS | Alpha Tau Medical Ltd. | 1.21B | 1.94% | 212,388 | - |
| 340 | GDRX | GoodRx Holdings, Inc. | 1.20B | -2.49% | 913,942 | 785.23M |
| 341 | OMER | Omeros Corporation | 1.20B | -1.66% | 414,005 | 38.42M |
| 342 | VSTM | Verastem, Inc. | 1.20B | -2.09% | 2,458,800 | 87.53M |
| 343 | SNDX | Syndax Pharmaceuticals, Inc. | 1.19B | -1.77% | 787,996 | 252.25M |
| 344 | SLN | Silence Therapeutics plc | 1.18B | 0.08% | 1,703,040 | 615.00K |
| 345 | KARD | Kardigan, Inc. | 1.18B | -0.78% | 545,738 | - |
| 346 | AVLN | Avalyn Pharma Inc. | 1.17B | -3.30% | 190,322 | - |
| 347 | OMDA | Omada Health, Inc. | 1.16B | -0.37% | 356,037 | 309.76M |
| 348 | TDOC | Teladoc Health, Inc. | 1.15B | 0.55% | 1,478,376 | 2.49B |
| 349 | PRCT | PROCEPT BioRobotics Corporation | 1.14B | -0.90% | 443,475 | 337.34M |
| 350 | AORT | Artivion, Inc. | 1.13B | -2.92% | 195,644 | 471.47M |
| 351 | STAA | STAAR Surgical Company | 1.13B | 0.09% | 173,387 | 339.59M |
| 352 | BCAX | Bicara Therapeutics Inc. | 1.13B | -3.24% | 456,032 | - |
| 353 | LMRI | Lumexa Imaging Holdings, Inc. | 1.10B | 4.87% | 472,933 | 1.04B |
| 354 | IRMD | IRADIMED CORPORATION | 1.10B | -2.19% | 79,281 | 86.34M |
| 355 | REPL | Replimune Group, Inc. | 1.09B | -3.63% | 1,266,051 | - |
| 356 | VOR | Vor Biopharma Inc. | 1.08B | -3.48% | 363,963 | - |
| 357 | SPTX | Seaport Therapeutics, Inc. | 1.08B | -2.89% | 74,462 | - |
| 358 | SVRA | Savara Inc. | 1.06B | -7.82% | 1,739,398 | - |
| 359 | HSTM | HealthStream, Inc. | 1.06B | 0.49% | 111,029 | 321.12M |
| 360 | HROW | Harrow, Inc. | 1.06B | 0.43% | 693,399 | 275.59M |
| 361 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.06B | -4.34% | 264,809 | 730.02M |
| 362 | CBLL | CeriBell, Inc. | 1.05B | 0.07% | 239,884 | 101.96M |
| 363 | AHG | Akso Health Group | 1.05B | - | 1,110 | 13.83M |
| 364 | CTY | City Therapeutics, Inc. | 1.03B | 0.12% | 300,781 | 14.34M |
| 365 | AVBP | ArriVent BioPharma, Inc. | 1.03B | 8.49% | 1,469,367 | - |
| 366 | MNKD | MannKind Corporation | 1.02B | -0.63% | 2,328,888 | 393.63M |
| 367 | JANX | Janux Therapeutics, Inc. | 1.02B | -2.34% | 214,160 | 24.00M |
| 368 | MLTX | MoonLake Immunotherapeutics | 1.01B | -3.44% | 1,375,101 | - |
| 369 | CSTL | Castle Biosciences, Inc. | 1.01B | -0.09% | 106,553 | 357.28M |
| 370 | BBNX | Beta Bionics, Inc. | 1.01B | -0.72% | 398,586 | 119.01M |
| 371 | LTGO | Latigo Biotherapeutics, Inc. | 1.00B | -8.54% | 94,202 | - |
| 372 | IMTX | Immatics N.V. | 999.20M | -3.05% | 479,727 | 47.65M |
| 373 | SIBN | SI-BONE, Inc. | 963.60M | -0.28% | 261,169 | 213.60M |
| 374 | SGP | SpyGlass Pharma, Inc. | 945.91M | 0.21% | 50,216 | - |
| 375 | ODTX | Odyssey Therapeutics, Inc. | 943.99M | 3.25% | 141,224 | 99.00K |
| 376 | IART | Integra LifeSciences Holdings Corporation | 932.49M | -2.72% | 737,134 | 1.66B |
| 377 | JBIO | Jade Biosciences, Inc. | 928.52M | -2.08% | 424,367 | - |
| 378 | QDEL | QuidelOrtho Corporation | 925.08M | 0.07% | 807,781 | 2.67B |
| 379 | CGEM | Cullinan Therapeutics, Inc. | 923.49M | -3.82% | 282,921 | - |
| 380 | GLUE | Monte Rosa Therapeutics, Inc. | 916.27M | -3.33% | 360,917 | 28.73M |
| 381 | RIGL | Rigel Pharmaceuticals, Inc. | 893.27M | -2.13% | 55,043 | 276.79M |
| 382 | CRVS | Corvus Pharmaceuticals, Inc. | 879.48M | -1.83% | 601,942 | - |
| 383 | ALMS | Alumis Inc. | 878.87M | -0.44% | 811,191 | 7.40M |
| 384 | AKTS | Aktis Oncology, Inc. | 876.56M | -5.97% | 132,986 | 10.06M |
| 385 | MGTX | MeiraGTx Holdings plc | 875.91M | -6.65% | 343,761 | 397.50M |
| 386 | OBX | Obsidian Therapeutics, Inc. | 864.82M | 0.43% | 225,117 | - |
| 387 | IVA | Inventiva S.A. | 857.31M | 4.31% | 3,462,109 | 2.81M |
| 388 | ANRO | Alto Neuroscience, Inc. | 856.46M | -1.69% | 231,839 | - |
| 389 | KURA | Kura Oncology, Inc. | 848.24M | -3.30% | 1,035,195 | 77.23M |
| 390 | GMRS | GMR Solutions Inc. | 836.29M | -0.09% | 178,790 | 5.88B |
| 391 | ABUS | Arbutus Biopharma Corporation | 831.95M | -0.12% | 1,557,032 | 181.72M |
| 392 | PHAR | Pharming Group N.V. | 820.05M | 2.24% | 19,157 | 366.48M |
| 393 | INMD | InMode Ltd. | 805.88M | -0.21% | 285,596 | 374.63M |
| 394 | AHCO | AdaptHealth Corp. | 798.45M | -3.00% | 929,857 | 3.36B |
| 395 | APMD | Apnimed, Inc. | 787.45M | 2.08% | 174,049 | 115.12M |
| 396 | PHR | Phreesia, Inc. | 785.82M | -0.47% | 385,157 | 507.79M |
| 397 | VREX | Varex Imaging Corporation | 775.73M | -0.03% | 214,483 | 865.00M |
| 398 | ARDX | Ardelyx, Inc. | 756.28M | -5.16% | 3,135,428 | 450.89M |
| 399 | COLL | Collegium Pharmaceutical, Inc. | 746.17M | -2.47% | 424,103 | 808.21M |
| 400 | SLBT | SL Science Holding Limited | 741.35M | -0.76% | 11,065 | 3.27M |
| 401 | HELP | Helus Pharma Inc. | 724.03M | -5.62% | 1,468,949 | - |
| 402 | CTKB | Cytek Biosciences, Inc. | 722.06M | 2.30% | 378,448 | 206.71M |
| 403 | GERN | Geron Corporation | 703.51M | -3.10% | 8,748,696 | 204.56M |
| 404 | ANNX | Annexon, Inc. | 701.44M | -2.89% | 1,399,110 | - |
| 405 | SANA | Sana Biotechnology, Inc. | 693.02M | -2.32% | 1,175,701 | - |
| 406 | STLN | Starling Oncology, Inc. | 684.88M | -2.75% | 662,977 | 587.24M |
| 407 | IAM | Iambic Therapeutics, Inc. | 682.57M | -1.84% | 491,551 | 18.25M |
| 408 | ANL | Adlai Nortye Group Ltd. | 681.97M | 0.09% | 61,262 | 18.06M |
| 409 | SGMT | Sagimet Biosciences Inc. | 678.60M | -3.82% | 473,171 | - |
| 410 | IMMX | Immix Biopharma, Inc. | 671.51M | -2.99% | 854,369 | - |
| 411 | DNA | Ginkgo Bioworks Holdings, Inc. | 666.00M | 1.85% | 818,884 | 132.42M |
| 412 | OABI | OmniAb, Inc. | 665.89M | -4.18% | 971,249 | 38.46M |
| 413 | ACHV | Achieve Life Sciences, Inc. | 665.78M | -0.46% | 330,123 | - |
| 414 | NVCT | Nuvectis Pharma, Inc. | 650.16M | -4.48% | 53,248 | - |
| 415 | AURA | Aura Biosciences, Inc. | 649.71M | -3.02% | 388,679 | - |
| 416 | PRME | Prime Medicine, Inc. | 643.12M | -3.08% | 3,768,396 | 4.07M |
| 417 | DSGN | Design Therapeutics, Inc. | 639.58M | -2.57% | 107,929 | - |
| 418 | PACB | Pacific Biosciences of California, Inc. | 638.76M | -0.24% | 3,496,504 | 159.27M |
| 419 | KIDS | OrthoPediatrics Corp. | 636.56M | -1.34% | 108,476 | 252.72M |
| 420 | SLDB | Solid Biosciences Inc. | 633.17M | -4.60% | 504,721 | - |
| 421 | LXRX | Lexicon Pharmaceuticals, Inc. | 631.84M | -4.70% | 1,923,199 | 41.47M |
| 422 | SOPH | SOPHiA GENETICS SA | 629.09M | 4.82% | 366,009 | 86.17M |
| 423 | ATTO | Attovia Therapeutics, Inc. | 622.68M | -5.93% | 176,463 | 1.80M |
| 424 | WVE | Wave Life Sciences, Inc. | 620.70M | -5.97% | 1,969,378 | 65.37M |
| 425 | GYRE | Gyre Therapeutics, Inc. | 616.06M | -0.85% | 116,736 | 109.82M |
| 426 | CRMD | CorMedix Inc. | 611.08M | -3.21% | 577,891 | 462.25M |
| 427 | CADL | Candel Therapeutics, Inc. | 610.62M | -4.77% | 859,233 | - |
| 428 | FDMT | 4D Molecular Therapeutics, Inc. | 598.85M | -8.52% | 600,856 | 92.01M |
| 429 | WEAV | Weave Communications, Inc. | 591.59M | 0.07% | 993,115 | 257.79M |
| 430 | CLYM | Climb Bio, Inc. | 585.56M | -3.27% | 300,935 | - |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 584.93M | -4.65% | 607,755 | 136.07M |
| 432 | DBVT | DBV Technologies S.A. | 582.24M | -0.15% | 184,581 | 5.04M |
| 433 | AVR | Anteris Technologies Global Corp. | 574.24M | -1.83% | 634,853 | 2.24M |
| 434 | IRWD | Ironwood Pharmaceuticals, Inc. | 570.08M | -3.36% | 825,721 | 389.32M |
| 435 | MDXG | MiMedx Group, Inc. | 565.55M | -1.27% | 817,839 | 355.17M |
| 436 | PBYI | Puma Biotechnology, Inc. | 564.21M | -2.93% | 396,221 | 231.24M |
| 437 | ETRA | Electra Therapeutics, Inc. | 559.25M | -3.68% | 106,715 | - |
| 438 | ACRS | Aclaris Therapeutics, Inc. | 558.62M | -0.91% | 1,201,068 | 8.22M |
| 439 | OLMA | Olema Pharmaceuticals, Inc. | 558.23M | -9.12% | 1,414,727 | - |
| 440 | EVO | Evotec SE | 558.20M | -1.30% | 14,222 | 819.47M |
| 441 | FLGT | Fulgent Genetics, Inc. | 553.88M | 0.70% | 113,668 | 323.93M |
| 442 | MYGN | Myriad Genetics, Inc. | 553.81M | 0.52% | 1,590,439 | 806.60M |
| 443 | CBIO | Crescent Biopharma, Inc. | 550.64M | -2.09% | 208,716 | 11.88M |
| 444 | STTK | Shattuck Labs, Inc. | 545.98M | -2.86% | 367,880 | 1.00M |
| 445 | EVH | Evolent Health, Inc. | 543.25M | -1.74% | 554,260 | 2.10B |
| 446 | TCMD | Tactile Systems Technology, Inc. | 534.37M | 0.21% | 78,862 | 350.31M |
| 447 | ANGO | AngioDynamics, Inc. | 518.74M | 2.62% | 458,569 | 325.38M |
| 448 | DRUG | Bright Minds Biosciences Inc. | 513.24M | -0.21% | 44,614 | - |
| 449 | CTMX | CytomX Therapeutics, Inc. | 512.06M | -3.69% | 1,949,205 | 18.30M |
| 450 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 451 | VALN | Valneva SE | 503.52M | -1.21% | 5,132 | 163.30M |
| 452 | AQST | Aquestive Therapeutics, Inc. | 503.30M | -2.91% | 1,372,138 | 54.09M |
| 453 | ENTX | Entera Bio Ltd. | 502.64M | -4.30% | 151,614 | 42.00K |
| 454 | DCTH | Delcath Systems, Inc. | 497.93M | -2.71% | 190,735 | 95.42M |
| 455 | SGHT | Sight Sciences, Inc. | 496.34M | -0.88% | 223,962 | 83.38M |
| 456 | OCS | Oculis Holding AG | 495.71M | -0.74% | 141,420 | 1.45M |
| 457 | INDP | Indaptus Therapeutics, Inc. | 491.46M | 7.02% | 241,298 | - |
| 458 | RCEL | AVITA Medical, Inc. | 479.37M | 0.52% | 308,606 | 75.63M |
| 459 | NRC | NRC Health | 479.33M | 1.36% | 64,514 | 140.00M |
| 460 | MNPR | Monopar Therapeutics Inc. | 473.28M | -2.85% | 44,516 | - |
| 461 | ARVN | Arvinas, Inc. | 472.74M | -6.35% | 395,853 | 316.70M |
| 462 | MASS | 908 Devices Inc. | 471.20M | 0.44% | 135,466 | 60.84M |
| 463 | CERS | Cerus Corporation | 470.56M | 1.08% | 718,549 | 221.55M |
| 464 | BLSM | BlossomHill Therapeutics, Inc. | 469.46M | -6.58% | 56,568 | - |
| 465 | PHAT | Phathom Pharmaceuticals, Inc. | 469.43M | -15.69% | 3,635,669 | 239.66M |
| 466 | NGNE | Neurogene Inc. | 468.27M | -3.62% | 76,860 | 925.00K |
| 467 | DMAC | DiaMedica Therapeutics Inc. | 466.46M | 0.23% | 67,886 | - |
| 468 | EOLS | Evolus, Inc. | 459.05M | -6.21% | 344,351 | 316.49M |
| 469 | SSII | SS Innovations International, Inc. | 455.88M | -4.01% | 38,097 | 52.40M |
| 470 | FTH | Faeth Therapeutics, Inc. | 451.82M | -13.01% | 253,292 | - |
| 471 | KMDA | Kamada Ltd. | 447.72M | 0.65% | 31,174 | 191.85M |
| 472 | MPLT | MapLight Therapeutics, Inc. | 446.83M | -2.55% | 231,325 | - |
| 473 | SRZN | Surrozen, Inc. | 446.04M | -0.99% | 231,893 | 11.51M |
| 474 | AGMB | AgomAb Therapeutics NV | 445.20M | -2.38% | 38,982 | - |
| 475 | EPRX | Eupraxia Pharmaceuticals Inc. | 443.77M | -11.26% | 254,920 | - |
| 476 | RGNX | REGENXBIO Inc. | 442.95M | -6.42% | 1,013,559 | 174.48M |
| 477 | NPCE | NeuroPace, Inc. | 440.04M | -2.44% | 35,168 | 106.99M |
| 478 | BWAY | BrainsWay Ltd. | 439.66M | -1.92% | 36,078 | 60.70M |
| 479 | ALLO | Allogene Therapeutics, Inc. | 426.68M | -1.20% | 7,530,259 | 4.64M |
| 480 | PRTA | Prothena Corporation plc | 420.96M | -0.61% | 254,754 | 54.53M |
| 481 | PROK | ProKidney Corp. | 420.53M | -2.73% | 300,328 | 818.00K |
| 482 | TLRY | Tilray Brands, Inc. | 416.52M | -3.07% | 3,134,505 | 963.10M |
| 483 | OVID | Ovid Therapeutics Inc. | 415.98M | -10.13% | 1,467,426 | 1.58M |
| 484 | SRTA | Strata Critical Medical, Inc. | 412.70M | -0.96% | 285,002 | 255.98M |
| 485 | ALT | Altimmune, Inc. | 412.38M | -2.30% | 1,979,197 | 31.00K |
| 486 | AUTL | Autolus Therapeutics plc | 407.23M | -3.16% | 1,255,116 | 117.39M |
| 487 | RZLT | Rezolute, Inc. | 405.95M | 0.26% | 880,126 | - |
| 488 | SI | Shoulder Innovations, Inc. | 404.30M | -1.67% | 37,479 | 60.06M |
| 489 | ASMB | Assembly Biosciences, Inc. | 404.16M | -2.12% | 128,899 | 74.85M |
| 490 | SPRY | ARS Pharmaceuticals, Inc. | 401.27M | -6.60% | 963,747 | 116.93M |
| 491 | SENS | Senseonics Holdings, Inc. | 400.79M | 2.43% | 341,244 | 48.55M |
| 492 | OFIX | Orthofix Medical Inc. | 398.77M | -2.00% | 152,501 | 833.19M |
| 493 | TKNO | Alpha Teknova, Inc. | 397.98M | 4.88% | 515,464 | 43.70M |
| 494 | CTEV | Claritev Corporation | 397.67M | -0.15% | 335,703 | 994.67M |
| 495 | NAUT | Nautilus Biotechnology, Inc. | 397.04M | 20.00% | 12,390,701 | 190.00K |
| 496 | CYH | Community Health Systems, Inc. | 393.71M | -0.17% | 515,682 | 11.98B |
| 497 | CARL | Carlsmed, Inc. | 393.57M | -1.33% | 40,429 | 63.30M |
| 498 | EIKN | Eikon Therapeutics, Inc. | 392.70M | -12.01% | 240,756 | - |
| 499 | TECX | Tectonic Therapeutic, Inc. | 390.79M | -5.22% | 70,555 | - |
| 500 | AUNA | Auna S.A. | 384.13M | 3.18% | 181,925 | 1.37B |